ASCO Education

191 Folgen

1. Self-Evaluation: Head & Neck Cancer

   Vom: 1.5.2019
2. ASCO Guidelines: Safe Handling of Hazardous Drugs

   Vom: 24.4.2019
3. Contrasting Cases: Frontline Immunotherapy in Metastatic Non-Small Cell Lung Cancer

   Vom: 17.4.2019
4. Contrasting Cases: Cancer Prevention

   Vom: 10.4.2019
5. ASCO Guidelines: Treatment of Multiple Myeloma

   Vom: 3.4.2019
6. ASCO Guidelines: Anticonvulsant Prophylaxis and Steroid Use in Adults with Metastatic Brain Tumors Endorsement

   Vom: 27.3.2019
7. ASCO Guidelines: Adjuvant Therapy for Resected Biliary Tract Cancer

   Vom: 20.3.2019
8. Self-Evaluation: Chemotherapy Dosing for Patients with Morbid Obesity

   Vom: 13.3.2019
9. Contrasting Cases: TAILORx- Chemotherapy or no?

   Vom: 6.3.2019
10. Self-Evaluation: Soft-Tissue Sarcomas-Epidemiology

    Vom: 27.2.2019
11. ASCO Guidelines: Adjuvant Endocrine Therapy for Women with Hormone Receptor Positive Breast Cancer Guideline

    Vom: 20.2.2019
12. Contrasting Cases: Nephrectomy

    Vom: 13.2.2019
13. Recent Approvals: Larotrectinib for the Treatment of Advanced Solid Tumors Containing NTRK Gene Fusion

    Vom: 6.2.2019
14. Recent Approvals: Duvelisib for Adult Patients with Relapsed or Refractory CLL or SLL

    Vom: 30.1.2019
15. ASCO Guidelines: Evaluating Susceptibility to Pancreatic Cancer PCO

    Vom: 16.1.2019
16. ASCO Guidelines: Hypofractionated Radiation Therapy for Localized Prostate Cancer Guideline

    Vom: 9.1.2019
17. Recent Approvals: Cemiplimab Approval for Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

    Vom: 2.1.2019
18. ASCO Guidelines: Initial Diagnostic Workup of Acute Leukemia Guideline

    Vom: 19.12.2018
19. New Drugs: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with Susceptible IDH1 Mutation

    Vom: 12.12.2018
20. Self-Assessment: Predictive and Prognostic Rule of Pathological Complete Response in Breast Cancer Treatment

    Vom: 5.12.2018